Page last updated: 2024-11-03

proglumetacin and Rheumatism

proglumetacin has been researched along with Rheumatism in 7 studies

proglumetacin : A carboxylic ester obtained by formal condensation of the carboxy group of indometacin with the hydroxy group of 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl N(2)-benzoyl-N,N-dipropyl-alpha-glutaminate. Used (as its dimaleate salt) to control pain and inflammation associated with musculoskeletal and joint disorders. Following oral administration, it is metabolised to indometacin and proglumide, a drug with antisecretory effects that helps prevent injury to the stomach lining.

Research Excerpts

ExcerptRelevanceReference
"Fifty-five patients with osteoarthritis, rheumatoid arthritis or spondyloarthritis, joint pain and other rheumatic-inflammatory disorders were treated with proglumetacin, at different doses, during 3-60 days."3.66[Proglumetacin: a flexible and broad-spectrum antirheumatic agent]. ( Fontanesi, G; Giancecchi, F; Rotini, R; Tartaglia, I, 1983)
"Proglumetacin was well-tolerated by all patients."1.26Proglumetacin (protacine): a promising new treatment of the rheumatic joint. ( Rivera, IC, 1982)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zanoli, S1
Pace, N1
Raffaelli, P1
Floris, F1
Fontanesi, G1
Giancecchi, F1
Rotini, R1
Tartaglia, I1
Benvenuti, M1
Albanese, L1
Pagliara, L1
Rivera, IC1
Branco do Amaral, A1
Pipitone, V1
Loizzi, P1
Casula, PL1
Bignamini, AA1

Trials

1 trial available for proglumetacin and Rheumatism

ArticleYear
Double-blind clinical evaluation of a new anti-inflammatory drug, protacine, versus indomethacin.
    Current medical research and opinion, 1979, Volume: 6, Issue:4

    Topics: Adult; Aged; Anti-Inflammatory Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans

1979

Other Studies

6 other studies available for proglumetacin and Rheumatism

ArticleYear
[Short-term study of proglumetacin].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Adult; Aged; Back Pain; Brachial Plexus Neuritis; Drug Evaluation; Drug Tolerance; Female; Humans; I

1983
[Proglumetacin: a flexible and safe anti-inflammatory agent for effective clinical practice].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Drug Eval

1983
[Proglumetacin: a flexible and broad-spectrum antirheumatic agent].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Child; Drug Evaluation; Drug Tolerance; Female; Huma

1983
[Clinico-statistical study on the anti-inflammatory activity of proglumetacin. Proglumetacin: at last a complete anti-inflammatory agent?].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Adult; Aged; Drug Evaluation; Drug Tolerance; Female; Gout; Humans; Indoleacetic Acids; Intervertebr

1983
Proglumetacin (protacine): a promising new treatment of the rheumatic joint.
    Pharmatherapeutica, 1982, Volume: 3, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Female; Humans; Indoleacetic Acids; Jo

1982
Short-term and long-term open evaluation of the efficacy and tolerance of proglumetacin, a new antirheumatic agent.
    Pharmatherapeutica, 1982, Volume: 3, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Arthritis; Chronic Disease; Female; Humans; Indoleacetic Acids; Mal

1982